Journal of Literature Pharmacy Sciences

Kozmetik Ürünlerin Toksisitesi: Endokrin Bozucu Kimyasallar
Toxicity of Cosmetic Products: Endocrine Disruptor Chemicals
Ecem Fatma KARAMANa, Sibel ÖZDENa
aFarmaötik Toksikoloji AD, İstanbul Üniversitesi Eczacılık Fakültesi, İstanbul, TÜRKİYE
J Lit Pharm Sci. 2019;8(2):138-46
doi: 10.5336/pharmsci.2018-64070
Article Language: TR
Full Text
ÖZET
Kozmetik ürünler; günlük yaşamda sürekli kullanılan ve maruz kalınan tüketim ürünleri olup, içeriğinde yer alan pek çok madde düşük maruziyet konsantrasyonları nedeni ile güvenli kabul edilebilmektedir. Kozmetik ürünlerin toksik etkileri için kozmetik ürüne maruziyet, uygulama alanı, uygulanan ürünün miktarı, uygulama süresi ve sıklığı gibi pek çok parametre dikkate alınmalıdır. Kozmetiklerde kullanılan kimyasallara maruziyet sonucu en bilinen yan etkiler; kontakt dermatit, irritasyon, fototoksisite, fotoalerji gibi reaksiyonlardır. Bu yan etkilere ek olarak, kozmetik ürünlere sürekli maruziyet sonucu sistemik toksik etkilerin de görülebileceği göz önünde bulundurulmalıdır. Özellikle, gebelerin endokrin bozucu kimyasallar içeren kozmetik ürünlere maruziyetinin fetüste ciddi sağlık sorunlarının ortaya çıkmasına neden olabileceği ileri sürülmektedir. Hazırlanan bu çalışmada, kozmetik ürünler aracılığıyla maruz kalınabilecek endokrin bozucu kimyasalların toksisitesinin ele alınması amaçlanmıştır.

Anahtar Kelimeler: Kozmetik ürünler; endokrin bozucu kimyasallar; Ftalatlar; Parabenler; bisfenol A
ABSTRACT
Cosmetic products are consumables that are used constantly in daily life. Ingredients of these products are considered to be safe due to low exposure concentrations. However, for the toxic effects of cosmetic products many parameters such as exposure, application area and amount of applied product, duration and frequency of application should be taken into consideration. The most common adverse effects are contact dermatitis, irritation, phototoxicity, photoallergy reactions at the result of exposure of chemicals used in cosmetics. In addition to these side effects, continuous exposure to endocrine disrupting chemicals through cosmetic products might result in serious adverse effects. Especially, it has been suggested that exposure to these chemicals in pregnant women could cause serious health problems in fetuses. In this review, the toxicity of endocrine disrupting chemicals that can be exposed through cosmetic products has been discussed.

Keywords: Cosmetic products; endocrine disruptor chemicals; Phtalates; Parabens; bisphenol A
REFERENCES:
  1. Resmi Gazete (23.05.25/25823), 5324 sayılı Kozmetik Kanunu; 2005. p.1.
  2. Nohynek GJ, Antignac E, Re T, Toutain H. Safety assessment of personal care products/cosmetics and their ingredients. Toxicol Appl Pharmacol. 2010;243(2):239-59. [Crossref] [PubMed]
  3. Türkiye İlaç ve Tibbi Cihaz Kurumu, Kozmetik Ürünlerde Güvenlilik Değerlendirmesine İlişkin Kılavuz Sürüm 2.0. Erişim Tarihi: 19 Kasım 2018.
  4. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance); 2009.
  5. Türkiye İlaç ve Tibbi Cihaz Kurumu, Kozmetik Ürünler Üzerinde Yapilan Hayvan Deneylerine Alternatif Test Metotlarina İlişkin Kılavuz Sürüm 1.0. Erişim Tarihi: 19 Kasım 2018.
  6. Colborn T, Clement C. Chemically-Induced Alterations in Sexual and Functional Development: the Wildlife/Human Connection. 1st ed. Princeton, NJ: Princeton Scientific Pub. Co; 1992. p.403.
  7. Colborn T, Dumanoski D, Myers J. Our Stolen Future: Are We Threatening Our Fertility, Intelligence, and Survival?: A Scientific Detective Story. 1st ed. New York, NY: Dutton; 1996. p.306.
  8. Damstra T, Barlow S, Bergman A, Kavlock R, van der Kraak G. Global Assessment of the State-of-the-Science of Endocrine Disruptors. Geneva: WHO/IPCS/EDC/02.2; 2002. p.133.
  9. Nicolopoulou-Stamati P, Hens L, Sasco AJ. Cosmetics as endocrine disruptors: are they a health risk? Rev Endocr Metab Disord. 2015;16(4):373-83. [Crossref] [PubMed]
  10. Caliman FA, Gavrilescu M. Pharmaceuticals, personal care products and endocrine disrupting agents in the environment-a review. Clean-Soil Air Water. 2009;37:277-303. [Crossref]
  11. Boberg J, Taxvig C, Christiansen S, Hass U. Possible endocrine disrupting effects of parabens and their metabolites. Reprod Toxicol. 2010;30(2):301-12. [Crossref] [PubMed]
  12. Maipas S, Nicolopoulou-Stamati P. Sun lotion chemicals as endocrine disruptors. Hormones (Athens). 2015;14(1):32-46. [Crossref] [PubMed]
  13. Helm JS, Nishioka M, Brody JG, Rudel RA, Dodson RE. Measurement of endocrine disrupting and asthma-associated chemicals in hair products used by black women. Environ Res. 2018;165:448-58. [Crossref] [PubMed]
  14. Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrinedisrupting chemicals. Environ Health Perspect. 2007;115(Suppl 1):98-105. [Crossref] [PubMed] [PMC]
  15. National Research Council (NRC). Phthalates and Cumulative Risk Assessment: the Tasks Ahead. Washington, DC: The National Academies Press; 2008. p.66. [Link]
  16. Schug TT, Abagyan R, Blumberg B, Collins TJ, Crews D, DeFur PL, et al. Designing endocrine disruption out of the next generation of chemicals. Green Chem. 2013;15(1):181-98. [Crossref] [PubMed] [PMC]
  17. Bois FY, Golbamaki-Bakhtyari N, Kovarich S, Tebby C, Gabb HA, Lemazurier E. High-throughput analysis of ovarian cycle disruption by mixtures of aromatase inhibitors. Environ Health Perspect. 2017;125(7):077012. [Crossref] [PubMed] [PMC]
  18. Melo LP, Queiroz ME. Simultaneous analysis of parabens in cosmetic products by stir bar sorptive extraction and liquid chromatography. J Sep Sci. 2010;33(12):1849-55. [Crossref] [PubMed]
  19. Royal Society of Chemistry. ChemSpider (Chemical structure database). Erişim Tarihi: 19 Kasım 2018. [Link]
  20. Karpuzoglu E, Holladay SD, Gogal RM Jr. Parabens: potential impact of low-affinity estrogen receptor binding chemicals on human health. J Toxicol Environ Health B Crit Rev. 2013;16(5):321-35. [Crossref] [PubMed]
  21. Survey of Parabens. Part of the LOUS-review. Environmental Project No. 1474. Denmark: Danish Environmental Protection Agency; 2013. p.54. Accessed 10 Sep 2015. Erişim Tarihi: 17 Kasım 2018. [Link]
  22. Charles AK, Darbre PD. Combinations of parabens at concentrations measured in human breast tissue can increase proliferation of MCF-7 human breast cancer cells. J Appl Toxicol. 2013;33(5):390-8. [Crossref] [PubMed]
  23. Wróbel AM, Gregoraszczuk EŁ. Action of methyl-, propyland butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells. Toxicol Lett. 2015;238(2): 110-6. [Crossref] [PubMed]
  24. Klopčič I, Kol?ek K, Dolenc MS. Glucocorticoid-like activity of propylparaben, butylparaben, diethylhexyl phthalate and tetramethrin mixtures studied in the MDA-kb2 cell line. Toxicol Lett. 2015;232(2):376-83.[Crossref] [PubMed]
  25. Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol. 2008;28(5):561-78. [Crossref] [PubMed]
  26. Kawaguchi M, Irie K, Morohoshi K, Watanabe G, Taya K, Morita M, et al. Maternal isobutylparaben exposure alters anxiety and passive avoidance test performance in adult male rats. Neurosci Res. 2009;65(2):136-40. [Crossref] [PubMed]
  27. Kawaguchi M, Morohoshi K, Imai H, Morita M, Kato N, Himi T. Maternal exposure to isobutylparaben impairs social recognition in adult female rats. Exp Anim. 2010;59(5):631-5. [Crossref] [PubMed]
  28. Oishi S. Effects of propyl paraben on the male reproductive system. Food Chem Toxicol. 2002;40(12):1807-13. [Crossref]
  29. Oishi S. Effects of butyl paraben on the male reproductive system in mice. Arch Toxicol. 2002;76(7):423-9. [Crossref] [PubMed]
  30. Maske P, Dighe V, Vanage G. n-butylparaben exposure during perinatal period impairs fertility of the F1 generation female rats. Chemosphere. 2018;213:114-23. [Crossref] [PubMed]
  31. Kolatorova L, Vitku J, Hampl R, Adamcova K, Skodova T, Simkova M, et al. Exposure to bisphenols and parabens during pregnancy and relations to steroid changes. Environ Res. 2018;163:115-22. [Crossref] [PubMed]
  32. Grecco CF, Souza ID, Queiroz MEC. Recent development of chromatographic methods to determine parabens in breast milk samples: a review. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1093-1094:82-90. [Crossref] [PubMed]
  33. Rastogi SK, Kesavachandran C, Mahdi F, Pandey A. Phthalate exposure and health outcomes. Indian J Occup Environ Med. 2006;10(3):111-5. [Crossref]
  34. Pak VM, McCauley LA, Pinto-Martin J. Phthalate exposures and human health concerns: a review and implications for practice. AAOHN J. 2011;59(5):228-33. [Crossref] [PubMed]
  35. Huang PC, Liou SH, Ho IK, Chiang HC, Huang HI, Wang SL. Phthalates exposure and endocrinal effects: an epidemiological review. J Food Drug Anal. 2012;20(4):719-33.
  36. Zhang J, Liu L, Wang X, Huang Q, Tian M, Shen H. Low-level environmental phthalate exposure associates with urine metabolome alteration in a Chinese male cohort. Environ Sci Technol. 2016;50(11):5953-60. [Crossref] [PubMed]
  37. Güven C, Dal F, Aydoğan Ahbab M, Taskin E, Ahbab S, Adin Çinar S, et al. Low dose monoethyl phthalate (MEP) exposure triggers proliferation by activating PDX-1 at 1.1B4 human pancreatic beta cells. Food Chem Toxicol. 2016;28(93):41-50. [Crossref] [PubMed]
  38. Harris S, Wegner S, Hong SW, Faustman EM. Phthalate metabolism and kinetics in an in vitro model of testis development. Toxicol In Vitro. 2016;32:123-31. [Crossref] [PubMed] [PMC]
  39. Duty SM, Silva MJ, Barr DB, Brock JW, Ryan L, Chen Z, et al. Phthalate exposure and human semen parameters. Epidemiology. 2003;14(3):269-77. [Crossref] [PubMed]
  40. López-Carrillo L, Hernández-Ramírez RU, Calafat AM, Torres-Sánchez L, Galván-Portillo M, Needham LL, et al. Exposure to phthalates and breast cancer risk in northern Mexico. Environ Health Perspect. 2010;118(4):539-44. [Crossref] [PubMed] [PMC]
  41. Jurewicz J, Hanke W. Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies. Int J Occup Med Environ Health. 2011;24(2):115-41. [Crossref]
  42. Wang YX, Zeng Q, Sun Y, You L, Wang P, Li M, et al. Phthalate exposure in association with serum hormone levels, sperm DNA damage and spermatozoa apoptosis: a cross-sectional study in China. Environ Res. 2015;150:557-65. [Crossref] [PubMed]
  43. Rodríguez-Carmona Y, Cantoral A, TrejoValdivia B, Téllez-Rojo MM, Svensson K, Peterson KE, et al. Phthalate exposure during pregnancy and long-term weight gain in women. Environ Res. 2019;169:26-32. [Crossref] [PubMed]
  44. Xie F, Chen X, Weng S, Xia T, Sun X, Luo T, et al. Effects of two environmental endocrine disruptors di-n-butyl phthalate (DBP) and mono-n-butyl phthalate (MBP) on human sperm functions in vitro. Reprodu Toxicol. 2019;83:1-7. [Crossref] [PubMed]
  45. Machtinger R, Berman T, Adir M, Mansur A, Baccarelli AA, Racowsky C, et al. Urinary concentrations of phthalate metabolites, bisphenols and personal care product chemical biomarkers in pregnant women in Israel. Environ Int. 2018;116:319-25. [Crossref] [PubMed]
  46. Berger KP, Kogut KR, Bradman A, She J, Gavin Q, Zahedi R, et al. Personal care product use as a predictor of urinary concentrations of certain phthalates, parabens, and phenols in the HERMOSA study. J Expo Sci Environ Epidemiol. 2018;29(1):21-32. [Crossref] [PubMed] [PMC]
  47. Byshovets TF, Bariliak IR, Korkach VI, Spitkovskaya LD. [Gonadotoxic activity of glycols]. Gig Sanit. 1987;9:84-5.
  48. National Research Council (NRC). Acute Exposure Guideline Levels for Selected Airborne Chemicals. Vol. 7. Washington, DC: The National Academies Press; 2009. p.250. [PubMed].
  49. International Agency for Research on Cancer (IARC). 1,4 dioxane: IARC Monographs Supplement 7. p.14. 1987 Erişim Tarihi: 17 Kasım 2018. [Link]
  50. Tzonou A, Polychronopoulou A, Hsieh CC, Rebelakos A, Karakatsani A, Trichopoulos D. Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer. Int J Cancer. 1993;55(3):408-10. [Crossref] [PubMed]
  51. Xie J, Liu YH, Li LF, Wu YM. [A clinical analysis of fetal chromosomal aberration induced by paint and hair dye]. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(7):1651-3.
  52. Bolt HM, Golka K. The debate on carcinogenicity of permanent hair dyes: new insights. Crit Rev Toxicol. 2007;37(6):521-36. [Crossref] [PubMed]
  53. Uehara S, Inomata N, Suzuki A, Matsuura M, Aihara M. Severe contact urticarial syndrome due to oxidative hair dye containing paraaminophenol and sodium-methyl-oleoyltaurate. J Dermatol. 2014;41(6):560-1. [Crossref] [PubMed]
  54. Wang L, Zhao L, Jia X, Jiang L, Song Y, Ye Q, et al. Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α. Biomed Pharmacother. 2019;109:621-8. [Crossref] [PubMed]
  55. Noorimotlagh Z, Haghighi NJ, Ahmadimoghadam M, Rahim F. An updated systematic review on the possible effect of nonylphenol on male fertility. Environ Sci Pollut Res Int. 2017;24(4):3298-314. [Crossref] [PubMed]
  56. Tan BL, Kassim NM, Mohd MA. Assessment of pubertal development in juvenile male rats after sub-acute exposure to bisphenol A and nonylphenol. Toxicol Lett. 2003;143(3):261-70. [Crossref]
  57. Cardinali M, Maradonna F, Olivotto I, Bortoluzzi G, Mosconi G, Polzonetti-Magni AM, et al. Temporary impairment of reproduction in freshwater teleost exposed to nonylphenol. Reprod Toxicol. 2004;18(4):597-604. [Crossref] [PubMed]
  58. Wolstenholme JT, Rissman EF, Connelly JJ. The role of Bisphenol A in shaping the brain, epigenome and behavior. Horm Behav. 2011;59(3):296-305. [Crossref] [PubMed] [PMC]
  59. European Food Safety Authority (EFSA). Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC) on a request from the Commission on the toxicokinetics of Bisphenol A. The EFSA Journal. 2008;759:1-10. [Crossref]
  60. Li DK, Zhou Z, Miao M, He Y, Wang J, Ferber J, et al. Urine bisphenol-A (BPA) level in relation to semen quality. Fertil Steril. 2011;95(2):625-30.e1-4. [Crossref] [PubMed]
  61. Zhou Q, Miao M, Ran M, Ding L, Bai L, Wu T, et al. Serum bisphenol-A concentration and sex hormone levels in men. Fertil Steril. 2013;100(2):478-82. [Crossref] [PubMed]
  62. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol. 2007;24(2):199-224. [Crossref] [PubMed] [PMC]
  63. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev. 2009;30(1):75-95. [Crossref] [PubMed] [PMC]
  64. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006;66(11):5624632. [Crossref] [PubMed] [PMC]
  65. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008;300(11):1303-10. [Crossref] [PubMed]
  66. Wolff MS, Teitelbaum SL, McGovern K, Pinney SM, Windham GC, Galvez M, et al; Breast Cancer and Environment Research Program. Environmental phenols and pubertal development in girls. Environ Int. 2015;84:174-80. [Crossref] [PubMed] [PMC]
  67. Sanchez-Prado L, Llompart M, Lores M, García-Jares C, Bayona JM, Cela R. Monitoring the photochemical degradation of triclosan in wastewater by UV light and sunlight using solid-phase microextraction. Chemosphere. 2006;65(8):1338-47. [Crossref] [PubMed]
  68. Chaudhari U, Nemade H, Sureshkumar P, Vinken M, Ates G, Rogiers V, et al. Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2018;92(1):371-81. [Crossref] [PubMed] [PMC]
  69. Saley A, Hess M, Miller K, Howard D, KingHeiden TC. Cardiac toxicity of triclosan in developing zebrafish. Zebrafish. 2016;13(5): 399-404. [Crossref] [PubMed]
  70. Dann AB, Hontela A. Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol. 2011;31(4):285-311. [Crossref] [PubMed]
  71. Ha M, Zhang P, Li L, Liu C. Triclosan suppresses testicular steroidogenesis via the miR-6321/JNK/Nur77 cascade. Cell Physiol Biochem. 2018;50(6):2029-45. [Crossref] [PubMed]
  72. Klammer H, Schlecht C, Wuttke W, Schmutzler C, Gotthardt I, Köhrle J, et al. Effects of a 5-day treatment with the UV-filter octyl-methoxycinnamate (OMC) on the function of the hypothalamo-pituitary-thyroid function in rats. Toxicology. 2007;238(2-3):192-9. [Crossref] [PubMed]
  73. Guo LL, Liu XH, Qin DX, Gao L, Zhang HM, Liu JY, et al. [Effects of nanosized titanium dioxide on the reproductive system of male mice]. Zhonghua Nak Ke Xue. 2009;15(6): 517-22.
  74. Balmer ME, Buser HR, Müller MD, Poiger T. Occurrence of some organic UV filters in wastewater, in surface waters, and in fish from Swiss lakes. Environ Sci Technol. 2005;39(4): 953-62. [Crossref] [PubMed]
  75. Quintaneiro C, Teixeira B, Benedé JL, Chisvert A, Soares AMVM, Monteiro MS. Toxicity effects of the organic UV-filter 4-methylbenzylidene camphor in zebrafish embryos. Chemosphere. 2018;273-81. [Crossref] [PubMed]

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com